These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26271587)

  • 1. Discovery of selective N-[3-(1-methyl-piperidine-4-carbonyl)-phenyl]-benzamide-based 5-HT₁ F receptor agonists: Evolution from bicyclic to monocyclic cores.
    Zhang D; Blanco MJ; Ying BP; Kohlman D; Liang SX; Victor F; Chen Q; Krushinski J; Filla SA; Hudziak KJ; Mathes BM; Cohen MP; Zacherl D; Nelson DL; Wainscott DB; Nutter SE; Gough WH; Schaus JM; Xu YC
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4337-41. PubMed ID: 26271587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and evaluation of bicyclic benzamides as novel 5-HT1F receptor agonists.
    Zhang D; Kohlman D; Krushinski J; Liang S; Ying BP; Reilly JE; Dinn SR; Wainscott DB; Nutter S; Gough W; Nelson DL; Schaus JM; Xu YC
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6011-6. PubMed ID: 15546719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted 5-HT
    Vila-Pueyo M
    Neurotherapeutics; 2018 Apr; 15(2):291-303. PubMed ID: 29488143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel potent 5-HT(1F) receptor agonists: structure-activity studies of a series of substituted N-[3-(1-methyl-4-piperidinyl)-1H-pyrrolo[3,2-b]pyridin-5-yl]amides.
    Filla SA; Mathes BM; Johnson KW; Phebus LA; Cohen ML; Nelson DL; Zgombick JM; Erickson JA; Schenck KW; Wainscott DB; Branchek TA; Schaus JM
    J Med Chem; 2003 Jul; 46(14):3060-71. PubMed ID: 12825944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-Piperidin-4-ylidenemethyl-benzamides as δ-opioid receptor agonists for CNS indications: identifying clinical candidates.
    Dantzman CL; King MM; Ernst GE; Wang X; McCauley JP; Andisik DW; Brush K; Bui KH; Frietze W; Hoesch V; Liu J; Palmer WE; Spear N; Hudzik TJ; Wesolowski SS
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1174-8. PubMed ID: 22197137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of benzamides as potent human β3 adrenergic receptor agonists.
    Zhu C; Kar NF; Li B; Costa M; Dingley KH; Di Salvo J; Ha SN; Hurley AL; Li X; Miller RR; Salituro GM; Struthers M; Weber AE; Hale JJ; Edmondson SD
    Bioorg Med Chem Lett; 2016 Jan; 26(1):55-9. PubMed ID: 26590100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
    Franchini S; Prandi A; Baraldi A; Sorbi C; Tait A; Buccioni M; Marucci G; Cilia A; Pirona L; Fossa P; Cichero E; Brasili L
    Eur J Med Chem; 2010 Sep; 45(9):3740-51. PubMed ID: 20605276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N,N-Diethyl-4-[(3-hydroxyphenyl)(piperidin-4-yl)amino] benzamide derivatives: the development of diaryl amino piperidines as potent delta opioid receptor agonists with in vivo anti-nociceptive activity in rodent models.
    Jones P; Griffin AM; Gawell L; Lavoie R; Delorme D; Roberts E; Brown W; Walpole C; Xiao W; Boulet J; Labarre M; Coupal M; Butterworth J; St-Onge S; Hodzic L; Salois D
    Bioorg Med Chem Lett; 2009 Nov; 19(21):5994-8. PubMed ID: 19800791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing selective, high affinity ligands of 5-HT1D receptor by covalent dimerization of 5-HT1F ligands derived from 4-fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide.
    Choi SK; Green D; Ho A; Klein U; Marquess D; Taylor R; Turner SD
    J Med Chem; 2008 Jun; 51(12):3609-16. PubMed ID: 18507369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors.
    Vacher B; Bonnaud B; Funes P; Jubault N; Koek W; Assié MB; Cosi C; Kleven M
    J Med Chem; 1999 May; 42(9):1648-60. PubMed ID: 10229633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of pyridinylmethylenepiperidine derivatives as potent 5-HT
    Jin C; Yi C; Zhong W; Xue Y; Chen K; Deng K; Wang Z; Wang T
    Eur J Med Chem; 2021 Dec; 225():113782. PubMed ID: 34419891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT1F agonists.
    Steel SJ
    Handb Clin Neurol; 2024; 199():43-50. PubMed ID: 38307661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT1F receptor agonists in acute migraine treatment: a hypothesis.
    Ramadan NM; Skljarevski V; Phebus LA; Johnson KW
    Cephalalgia; 2003 Oct; 23(8):776-85. PubMed ID: 14510923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and SAR of N-(1-((substituted piperidin-4-yl)methyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide derivatives: 5-Hydroxytryptamine receptor 4 agonist as a potent prokinetic agent.
    Park JS; Im W; Choi S; Park SJ; Jung JM; Baek KS; Son HP; Sharma S; Kim IS; Jung YH
    Eur J Med Chem; 2016 Feb; 109():75-88. PubMed ID: 26761776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and structure-activity relationship of 3-methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide (APD791): a highly selective 5-hydroxytryptamine2A receptor inverse agonist for the treatment of arterial thrombosis.
    Xiong Y; Teegarden BR; Choi JS; Strah-Pleynet S; Decaire M; Jayakumar H; Dosa PI; Casper MD; Pham L; Feichtinger K; Ullman B; Adams J; Yuskin D; Frazer J; Morgan M; Sadeque A; Chen W; Webb RR; Connolly DT; Semple G; Al-Shamma H
    J Med Chem; 2010 Jun; 53(11):4412-21. PubMed ID: 20455563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of benzamide analogues as a novel class of 5-HT₃ receptor agonists.
    Jørgensen CG; Frølund B; Kehler J; Jensen AA
    ChemMedChem; 2011 Apr; 6(4):725-36. PubMed ID: 21246737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 5-HT(1) receptors inhibiting the rat vasodepressor sensory CGRPergic outflow: further involvement of 5-HT(1F), but not 5-HT(1A) or 5-HT(1D), subtypes.
    González-Hernández A; Manrique-Maldonado G; Lozano-Cuenca J; Muñoz-Islas E; Centurión D; Maassen VanDenBrink A; Villalón CM
    Eur J Pharmacol; 2011 Jun; 659(2-3):233-43. PubMed ID: 21473863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.
    Gray DL; Xu W; Campbell BM; Dounay AB; Barta N; Boroski S; Denny L; Evans L; Stratman N; Probert A
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6604-7. PubMed ID: 19854053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a series of aryl-N-(3-(alkylamino)-5-(trifluoromethyl)phenyl)benzamides as TRPA1 antagonists.
    Laliberté S; Vallée F; Fournier PA; Bedard L; Labrecque J; Albert JS
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3204-6. PubMed ID: 24880903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delta agonist hydroxy bioisosteres: the discovery of 3-((1-benzylpiperidin-4-yl){4-[(diethylamino)carbonyl]phenyl}amino)benzamide with improved delta agonist activity and in vitro metabolic stability.
    Griffin AM; Brown W; Walpole C; Coupal M; Adam L; Gosselin M; Salois D; Morin PE; Roumi M
    Bioorg Med Chem Lett; 2009 Nov; 19(21):5999-6003. PubMed ID: 19800790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.